BioTech/Drugs - South San Francisco, CA, US
Traumatic brain injury (TBI), multiple sclerosis (MS), post-traumatic epilepsy (PTE), Alzheimer's disease and related dementias (ADRD), chronic traumatic encephalopathy (CTE), and related indications are leading causes of death and disability.Gryphon Bio is a preclinical-stage therapeutic bioconjugate company created to harness our co-founders' discovery of novel therapeutic targets and temporal biomarkers in unexpected waves of brain molecules in the blood.Mission: To develop and market the 1st therapeutic bioconjugate to accelerate brain repair and improve cognition.Vision: To pioneer therapeutic bioconjugates to improve the lives of patients with neurological or neurodegenerative diseases.
Outlook
Varnish
Wix
Amazon AWS
Mobile Friendly